Jan 29, 2026 · 30m · no-priors
How Until is Engineering Away Time in Organ Transplants | Laura Deming
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of No Priors, Laura Deming, CEO of Until, explains how first-principles physics and advanced thermal engineering are making reversible cryopreservation viable, starting with organ transplant banking and paving the way for whole-body medical hibernation.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 23.6% of the talking time here. How this is scored →
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Deming firmly redirects Guo's hypothetical Mars travel use case, arguing that the social reality of abandoning everyone you know renders non-medical hibernation impractical.
Hardest push from the hosts ▶ 25:02 Challenging why the field sat neglectedGuo questions why mainstream science neglected cryobiology for decades if proven empirical milestones like viable re-implanted kidneys already existed.
Biggest teaching moment ▶ 13:40 Explaining probabilistic ice nucleationDeming walks through the fundamental physics of stochastic ice nucleation, showing how rapidly passing danger temperature thresholds prevents destructive crystal growth.
The host holds their own ▶ 18:05 Synthesizing engineering levers in organ vitrificationGuo demonstrates strong technical comprehension by articulating how adjusting geometric heating ratios and thermal distribution replaces purely biological interventions.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Episode Preview: Engineering Away Time Through Cryopreservation | 3 | 4 | 1 | 1 | Guo sets up the episode and asks Deming about her unconventional childhood and early conceptualization of aging. Deming explains how she realized longevity wasn't a fixed ceiling but an uncertain variable worth investigating. | |
| Founding the Longevity Fund and Shifting Focus to Cryopreservation | 3 | 3 | 1 | 1 | Guo asks what prompted the shift from venture capital at the Longevity Fund to founding Until. Deming describes cryopreservation as a foundational problem and details how her co-founder re-derived principles to confirm technical feasibility. | |
| Until's Core Mission: Medical Hibernation as Critical Care | 3 | 4 | 1 | 1 | Deming outlines Until's core mission of creating an 'ambulance for the future' through medical hibernation, distinguishing near-term organ preservation from long-term whole-body applications. | |
| The Social Reality and Psychological Costs of Time-Skipping | 4 | 4 | 2 | 2 | Guo raises sci-fi use cases like space travel to Mars, but Deming grounds the discussion in the severe psychological and social costs of leaving one's social network behind in time. | |
| Physics of Ice Nucleation and Empirical Precedents in Cryopreservation | 4 | 6 | 1 | 1 | Deming educates Guo on the stochastic physics of ice nucleation and notes existing precedents like human embryos preserved for over 30 years to prove that the core physics works. | |
| Trading Engineering Levers Against Biological Toxicity | 6 | 5 | 1 | 2 | Deming details how engineering controls over temperature allow teams to reduce toxic cryoprotective agents. Guo synthesizes the concept with concrete lab observations about surface-area-to-volume heating. | |
| Dual Research Tracks and the Open Question of Brain Preservation | 4 | 5 | 2 | 1 | Deming outlines their parallel rat and human organ research tracks, candidly noting that brain preservation remains a major scientific unknown and defining practical transplant milestones. | |
| Validating Cryobiology and Shifting Mainstream Perceptions | 4 | 5 | 1 | 1 | Deming highlights historical precedents by Greg Fahy and John Bischof to show organ vitrification is scientifically grounded, explaining the field's antimemetic reputational hurdles. | |
| Revolutionizing the Transplant Ecosystem for Patients and Surgeons | 3 | 3 | 0 | 0 | The interview concludes with Deming describing how removing time constraints liberates organ transplant logistics, before sharing her aesthetic passion for representing the molecular world. |